Thermo Fisher Scientific Inc. (TMO) EPS Diluted: 17.74
Is Thermo Fisher Scientific Inc.’s EPS diluted high or low?
Thermo Fisher Scientific Inc.'s EPS diluted of 17.74 is in line with its 5-year average of 17.13, around the middle of its 5-year range (15.45–19.46).
The EPS diluted for Thermo Fisher Scientific Inc. (TMO) is 17.74. It is above its 12-month average by 3.53% (17.13).
TMO EPS Diluted Chart
TMO Average EPS Diluted Chart
TMO Current vs Average EPS Diluted Chart
TMO EPS Diluted Metrics
EPS DILUTED
17.74
EPS DILUTED AVG TTM
17.13
EPS DILUTED AVG 3Y
16.84
EPS DILUTED AVG 5Y
17.13
EPS DILUTED AVG 10Y
12.26
EPS DILUTED AVG 15Y
9.51
EPS DILUTED AVG 20Y
7.64
CURRENT VS TTM AVG
+3.53%
CURRENT VS 3Y AVG
+5.34%
CURRENT VS 5Y AVG
+3.54%
CURRENT VS 10Y AVG
+44.75%
CURRENT VS 15Y AVG
+86.49%
CURRENT VS 20Y AVG
+132.29%
Thermo Fisher Scientific Inc. EPS Diluted Formula & Definition
EPS Diluted includes the effect of convertible securities, options, and other potential shares. Compare it with basic EPS to see the impact of potential dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Thermo Fisher Scientific Inc. EPS Diluted FAQ
- What is the EPS diluted for Thermo Fisher Scientific Inc. (TMO)?
- The EPS diluted for TMO stock is 17.74.
- Is Thermo Fisher Scientific Inc.'s EPS diluted high or low?
- Thermo Fisher Scientific Inc.'s EPS diluted of 17.74 is in line with its 5-year average of 17.13, around the middle of its 5-year range (15.45–19.46).
- What is the TTM average EPS diluted for Thermo Fisher Scientific Inc. (TMO)?
- The TTM average EPS diluted for TMO stock is 17.13.
- What is the 3Y average EPS diluted for Thermo Fisher Scientific Inc. (TMO)?
- The 3Y average EPS diluted for TMO stock is 16.84.
- What is the 5Y average EPS diluted for Thermo Fisher Scientific Inc. (TMO)?
- The 5Y average EPS diluted for TMO stock is 17.13.
- What is the 10Y average EPS diluted for Thermo Fisher Scientific Inc. (TMO)?
- The 10Y average EPS diluted for TMO stock is 12.26.
- What is the 15Y average EPS diluted for Thermo Fisher Scientific Inc. (TMO)?
- The 15Y average EPS diluted for TMO stock is 9.51.
- What is the 20Y average EPS diluted for Thermo Fisher Scientific Inc. (TMO)?
- The 20Y average EPS diluted for TMO stock is 7.64.
Thermo Fisher Scientific Inc. EPS Diluted History
| DATE | EPS DILUTED |
|---|---|
| 2025-12-31 | 17.74 |
| 2024-12-31 | 16.53 |
| 2023-12-31 | 15.45 |
| 2022-12-31 | 17.64 |
| 2021-12-31 | 19.46 |
| 2020-12-31 | 15.98 |
| 2019-12-31 | 9.17 |
| 2018-12-31 | 7.24 |
| 2017-12-31 | 5.59 |
| 2016-12-31 | 5.09 |
| 2015-12-31 | 4.92 |
| 2014-12-31 | 4.71 |
| 2013-12-31 | 3.48 |
| 2012-12-31 | 3.21 |
| 2011-12-31 | 3.46 |
| 2010-12-31 | 2.53 |
| 2009-12-31 | 2.01 |
| 2008-12-31 | 2.25 |
| 2007-12-31 | 1.72 |
| 2006-12-31 | 0.84 |
| 2005-12-31 | 1.36 |
| 2004-12-31 | 2.17 |
| 2003-12-31 | 1.20 |
| 2002-12-31 | 1.73 |
| 2001-12-31 | 0.00 |
| 2000-12-31 | -0.22 |
| 1999-12-31 | -1.10 |
| 1998-12-31 | 1.08 |
| 1997-12-31 | 1.41 |
| 1996-12-31 | 1.22 |
Related Metrics
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Marc N. Casper